It was identified that Ktrans and Kep alone did have high clinical value in the clinical staging and differentiation of HCC patients, both of which can improve the specificity and sensitivity of AFP in the clinical staging and differentiation of HCC patients through combined detection. This evidence concerns the gene AFP and hepatocellular carcinoma.